Earlier this week, the New York State Assembly passed the Medical Aid in Dying Act (A.136/S.138) with a narrow vote of 81-67. The four-hour debate revealed serious moral, legal, and practical concerns from legislators on both sides. Despite bipartisan opposition, the bill received majority support.
The legislation allows an adult patient of sound mind with a prognosis of less than six months to live to seek permission to self-administer a life-ending drug. Concerns about potential abuse and lack of safeguards for lethal medication were raised. Critics worry that family members might pressure patients into considering suicide to avoid care costs or responsibilities.
The bill’s language states: “The cause of death listed on a qualified individual’s death certificate who dies after self-administering medication under this article will be the underlying terminal illness or condition.” This has been interpreted as requiring doctors to ignore the true cause of death, which is seen as misleading.
The medical community is divided over the legislation. An American Medical Association code of ethics opinion highlights similar concerns: “Physician-assisted suicide is fundamentally incompatible with the physician’s role as healer, would be difficult or impossible to control, and would pose serious societal risks.”
Doctor-assisted suicide is not yet law in New York; it still requires Senate approval and Governor Hochul’s signature. Opponents argue that passing such legislation would essentially legalize suicide in New York.
Critics believe that instead of pursuing such measures, efforts should focus on improving mental health services, hospice, and palliative care. They argue that this bill does not honor those facing end-of-life decisions but rather creates risks for patients and ethical dilemmas for physicians.
